Drug Trial Radar · NCT03689244
A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery and/or Interventional Treatment
Last checked: Nov 20, 2026Latest source record: Jun 21, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
128
Actual
Start
Jan 23, 2019
Primary completion
Jun 7, 2022
Study completion Jun 7, 2022
Sponsor
- Lead sponsor
- ActelionJohnson & Johnson (Janssen) (JNJ)
- Sponsor type
- Industry
- First posted
- Sep 28, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Selexipag is available in many countries for the treatment of pulmonary arterial hypertension (PAH). Due to the similarities between PAH and chronic thromboembolic pulmonary hypertension (CTEPH) and the observed efficacy of other PAH medicines in CTEPH, it is believed that selexipag could benefit to patients with CTEPH. This study aims to assess the efficacy and safety of selexipag in participants with inoperable or persistent/recurrent CTEPH.
Conditions
- Chronic Thromboembolic Pulmonary Hypertension
Interventions
SelexipagDrug
oral tablets containing 200 µg of selexipag. Depending on the iMTD, participants will receive 1 to 8 tablets at each administration
PlaceboDrug
Oral tablets without active compound
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Pulmonary Vascular Resistance (PVR) at Week 20Time frame: Baseline (Day 1, pre-dose), within 2 to 5 hours post-dose on Week 20
Locations
162 sites in 31 countries. Site status is shown where the registry gives one.
University of California San Diego Medical Center
La Jolla, California
University of Southern California, Keck School of Medicine
Los Angeles, California
University of Colorado Anschutz Medical Campus
Aurora, Colorado
Colorado Springs Pulmonary Consultants
Colorado Springs, Colorado
South Denver Cardiology Associates PC
Littleton, Colorado
Mayo Clinic in Florida
Jacksonville, Florida
Piedmont Healthcare
Atlanta, Georgia
Emory University
Atlanta, Georgia
Northwestern University Feinberg School of Medicine
Chicago, Illinois
University of Chicago Hospitals - Chicago
Chicago, Illinois
Advocate Christ Medical Center
Oak Lawn, Illinois
University of Maryland
Baltimore, Maryland
University of Michigan
Ann Arbor, Michigan
Sparrow Clinical Research Institute
Lansing, Michigan
Mayo Clinic
Rochester, Minnesota
Washington University in St. Louis
St Louis, Missouri
University of Nebraska Medical Center
Omaha, Nebraska
St. Mary's Cardiology
Reno, Nevada
University of New Mexico Clinical & Translational Science Center
Albuquerque, New Mexico
Duke University Medical Center
Durham, North Carolina
University of Cincinnati Medical Center
Cincinnati, Ohio
Cleveland Clinic
Cleveland, Ohio
Temple University Hospital
Philadelphia, Pennsylvania
Allegheny
Pittsburgh, Pennsylvania
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania
University of Texas Southwestern Medical Center
Dallas, Texas
Houston Methodist Hospital
Houston, Texas
Baylor Scott & White Research Institute at The Heart Hospital Baylor Plano
Plano, Texas
Intermountain Medical Center
Murray, Utah
University of Utah Cardiovascular Center
Salt Lake City, Utah
Medical College of Wisconsin Froedtert Hospital
Milwaukee, Wisconsin
Aurora Saint Lukes Medical Center
Milwaukee, Wisconsin
Sanatorio de la Trinidad Mitre
Buenos Aires, Argentina
Centro Médico Dra. De Salvo
Buenos Aires, Argentina
Hospital Italiano de Buenos Aires
Caba, Argentina
Sanatorio Ramon Cereijo
Caba, Argentina
Instituto de Cardiología y Cirugía Cardiovascular - Fundación Favaloro
Caba, Argentina
Hospital General de Agudos Dr Cosme Argerich
CABA, Argentina
Hospital Britanico de Buenos Aires
CABA, Argentina
Royal Adelaide Hospital
Adelaide, Australia
Showing 40 of 162 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.